GreenBanana SEO celebrates 30th 5-star Google Review, Reinforcing Role as Best Generative Engine Optimization (GEO) Agency 
The Capital Architect Behind the Gala Robots: Shoucheng Holdings (0697.HK) Enters a Milestone Year of Value Re-rating 
Graphene Manufacturing Group and Tickford Racing Unite to Push Performance Efficiency On and Off the Track Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
HOUSTON, Jan. 28, 2021 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing…
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
First to Demonstrate Clinical Efficacy Against COVID-19 and Both UK and South Africa Variants Strong…
GENFIT Announces Two Key Appointments to the Executive Committee
Lille, France; Cambridge, MA; January 28, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage…
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical…
Evelo Biosciences Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical…
Oncternal Therapeutics Announces the Appointment of Dr. Rosemary Mazanet to the Board of Directors
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville District
New space is ideally equipped and located in the heart of Buffalo’s urban renewal WILLIAMSVILLE,…
Invitation to Idorsia’s full year financial results 2020 webcast and conference call
Idorsia will publish its full year financial results 2020 on Thursday February 4, 2021, at…
OSE Immunotherapeutics Expands its Collaboration with MAbSilico to Use Artificial Intelligence to Accelerate Drug Development of Novel Antibody Therapeutics
OSE is advancing an “Immunotherapy 2.0” future by leveraging MAbSilico’s artificial intelligence-powered software solutions and…
Biosenta Announces Note Financing
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Biosenta Inc. (“Biosenta” or the “Company”) listed on…
Marrone Bio Appoints Sue Cheung New Chief Financial Officer
DAVIS, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), an…
Ayala Pharmaceuticals Announces First Patient Dosed in Phase 2 TENACITY Clinical Trial of AL101 for the Treatment of Patients with Notch-Activated Triple Negative Breast Cancer
REHOVOT, Israel and WILMINGTON, Del., Jan. 28, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (NASDAQ:…
AskBio Adds CNS Gene Therapy Programs in Parkinson’s Disease and Multiple System Atrophy
Clinical team led by neurological gene therapy expert, Dr. Krystof Bankiewicz, joins AskBio RESEARCH TRIANGLE…
Aeterna Zentaris Expands Orphan Drug Development Pipeline with Targeted Immunosuppressive Therapeutics
– Company licenses exclusive worldwide rights to develop, manufacture and commercialize targeted, highly specific immunosuppressive…
AGTC Announces Pricing of Public Offering of Common Stock and Warrants
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
Adamis Pharmaceuticals and Human Immune Monitoring Center at Stanford University Announce Preliminary Tempol Data in Cells from COVID-19 Patients
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) in…
IceCure Announces a $15 Million Private Placement and Intention to Pursue NASDAQ Listing
Upon closing, the company to meet Nasdaq listing requirements without the need to effect a…
Soleno Therapeutics to Host Key Opinion Leader Meeting on DCCR for the Treatment of Prader-Willi Syndrome
Webinar on Thursday, February 4, at 12:00 PM ET REDWOOD CITY, Calif., Jan. 28, 2021…
COMPASS Pathways plc to participate in Canaccord Genuity’s New Paradigms and Treatment Approaches in Mental Health Conference
George Goldsmith, Chairman & CEO, to deliver opening day keynote on 3 February London, UK,…
Alkahest Announces Peer-Reviewed Publication Demonstrating Safety and Tolerability of GRF6019 in Patients with Mild-to-Moderate Alzheimer’s Disease
GRF6019 was safe and well-tolerated, and patients experienced no cognitive decline and minimal functional decline…